October 17, 2017 Cellectar Biosciences & Pierre Fabre Extend Collaboration for Development of New Phospholipid Drug Conjugates October 17, 2017 Cellectar Biosciences, Inc., an oncology-focused, clinical-stage biotechnology company, together with leading French pharmaceutical company Pierre Fabre, recently announced the extension...